ANNOUNCEMENTAnnouncement • February 2nd, 2023Contract TypeAnnouncementFiledFebruary 2nd, 2023Taiwan Liposome Company and Ablynx entered into a Feasibility Study Agreement for Nanobody-Immunoliposome Development
Taiwan Liposome Company and Ablynx entered into a Feasibility Study Agreement for Nanobody-Immunoliposome Development